$CHEK at $1.16 Price Target Lowered to $5.50 at HC Wainwright
Check-Cap Ltd. (NASDAQ:CHEK) had its price objective reduced by HC Wainwright from $7.00 to $5.50 in a research note issued to investors on Tuesday. The firm presently has a “buy” rating on the medical research company’s stock. HC Wainwright’s price objective indicates a potential upside of 433.98% from the stock’s previous close.
Other equities analysts also recently issued reports about the company. ValuEngine upgraded Check-Cap from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 17th. Maxim Group restated a “buy” rating and issued a $5.00 target price on shares of Check-Cap in a research note on Wednesday, September 27th. Finally, Zacks Investment Research upgraded Check-Cap from a “hold” rating to a “buy” rating and set a $2.00 target price for the company in a research note on Tuesday, October 3rd. One analyst has rated the stock with a sell rating and four have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $4.63.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.